RELVAR ELLIPTA is contraindicated in patients with severe milk-protein allergy or who have demonstrated hypersensitivity to either fluticasone furoate, vilanterol or any of the excipients.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
